Phase 2 Study of Androgen Deprivation Therapy (ADT) Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Degarelix (Primary) ; Doxorubicin; Estramustine; Ketoconazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Oct 2017 Status changed from recruiting to discontinued.
- 10 Jun 2017 Biomarkers information updated
- 12 Nov 2015 Planned End Date changed from 1 Oct 2023 to 1 Nov 2023 as reported by ClinicalTrials.gov.